Retatrutide
10mg · lyophilized · single vial
4.6(1,302 researcher reviews)Next-gen triple agonist. Research use only.
- HPLC3rd-party assay
- CoAPer batch
- Cold-chainIce-packed
- DiscreetPlain packaging
For research and educational use only. Not for human consumption. Consult a licensed provider before use.
What is Retatrutide?
Retatrutide is Lilly's investigational triple agonist of GLP-1, GIP and glucagon receptors. Phase 2 data showed up to 24% body-weight reduction at 48 weeks — outperforming semaglutide and tirzepatide in head-to-head comparisons.
Every KINETYX vial is filled in a controlled cleanroom and sealed with tamper-evident packaging. Batch documentation includes identity confirmation, HPLC purity analysis and concentration verification.
What researchers are saying
Sleep and recovery both improved
Jul 14, 2026Discreet packaging, tamper-evident seal, ships fast. Exactly what a research supplier should be.
E. BauerClinician✓ Verified buyerSleep and recovery both improved
Jun 28, 2026Recovery windows shortened noticeably. Sleep quality is the other clear signal.
H. NguyenWellness✓ Verified buyerVerified against the lab report
Jul 2, 2026Discreet packaging, tamper-evident seal, ships fast. Exactly what a research supplier should be.
A. RossiEndurance athleteVerified against the lab report
Jun 16, 2026Recovery windows shortened noticeably. Sleep quality is the other clear signal.
D. OkaforResearcher✓ Verified buyer